MedTrace Logo

Effect of Prime Solution on Fluid Balance After Open Heart Surgery

NCT00797589 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2015-08-25

No results posted yet for this study

Summary

The use of Tetraspan® as prime solution can reduce fluid extravasation after perfusion versus Ringer acetate. Plasma-adapted HES-solutions produce also less acidosis.

Conditions

  • Valve Surgery
  • Coronary Artery Bypass Grafting

Interventions

DRUG

HES

20ml/kg as prime fluid

DRUG

Ringer lactate

Sponsors & Collaborators

  • B. Braun Melsungen AG

    collaborator INDUSTRY

  • University of Helsinki

    lead OTHER

Principal Investigators

  • Raili T Suojaranta-Ylinen, MD, PhD · Helsinki University Central Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2012-09-30
Completion
2012-09-30

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00797589 on ClinicalTrials.gov